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Summary 
In an attempt to characterize genes participating in the allergic late phase reaction, we have isolated 
a novel intercrine/chemokine (called MARC)  from a cDNA library of the stimulated mouse 
mast cell line, CPlI. As measured by Northern blotting, it is strongly upregulated at the mRNA 
level after the physiological challenge of the cells with immunoglobulin (Ig)E plus antigen. 
Unstimulated cells completely lack significant, stable expression, as do a number of other, different 
cell lines (uninduced and induced) and mouse tissues. In contrast to the Northern blot analysis, 
a polymerase chain reaction (PCR)  analysis,  performed on CPII ceUs and on Perco11 gradient 
purified mouse peritoneal mast cells, revealed a basal level of transcription in the uninduced stage. 
After 2 h of IgE plus antigen challenge, a quantitative reverse transcriptase-PCR, using a spiked 
in MIMIC, showed a level of transcripts more than 100-fold higher in the CPII cells and 5-20- 
fold higher in purified mouse peritoneal cavity mast cells. This rapid induction after the Fc+RI 
challenge, the identification of the gene as a member of the chemokine family, and its upregulated 
expression in peritoneal  mast  cells,  all  suggest  an  involvement in certain  acute and chronic 
pathological mast cell-driven diseases. 
I  ntercrines/r  are small soluble proteins that regu- 
late the physiological tra~cking and the partial activation 
ofleukocytes (1). In contrast to most other known cytokines 
and lymphokines, chemokines show a considerable homology 
(identity and similarity) at the amino acid level Addition- 
ally,  they are characterized by a common protein structure 
of two loops formed via disulfide bridges of four highly con- 
served cysteines.  Based on the location of the  two  NH2- 
terminal cysteines, this superfamily is subdivided into a CXC 
(IL-8 or PF4 family) and CC (RANTES/sis family) branch 
(2, 3).  In the last,  six members in the human system and 
five corresponding mouse genes are currently isolated (4, 5). 
Spedfic sites of production in the body and the low amount 
produced in vivo make the direct isolation and characteriza- 
tion of these proteins from healthy individuals nearly impos- 
sible.  A  few members, like macrophage inflammatory pro- 
tein (MIP)-la,  MIP-IB and monocyte chemotactic protein 
(MCP)I, have been purified at protein level from overexpressing 
tumor cell lines by functional monitoring,  and the corre- 
sponding genes were subsequently identified (6,  7).  How- 
ever, the majority in the CC branch were isolated by induction- 
specific differential hybridization of cDNA libraries (see ref- 
erence 4). This reflects the fact that most members are strongly 
upregulated at the transcriptional level after cell activation 
(4). Supernatants from transiently transfected cell lines were 
used for a detailed functional analysis afterwards  (8). 
Type I allergic reactions are characterized at the level of 
mast cells by a biphasic response. In an immediate reaction 
(up to several minutes) preformed low molecular weight sub- 
stances, like histamine and serotonin, are released after IgE 
plus antigen binding to the cell (degranulation). Then, a less 
defined late phase reaction (starting after several hours) needs 
de novo transcription and protein synthesis and is probably 
mediated via certain lymphokines and chemokines. In an at- 
tempt to characterize genes participating in this late phase 
reaction, we have isolated a new member of the RANTES/sis 
superfamily using the approach of uninduced vs.  induced 
differential hybridization of a cDNA library from a mouse 
mast cell line. The new member has a significant homology 
to the mouseJE gene and protein (9), the human MCP1 gene 
and protein (10,  11), and two, only recently at protein level 
described  human  isolates,  designated  MCP2  (identical  to 
former partial isolate HC14)  and MCP3  (12,  13). 
Materials and Methods 
With minor modifications, the RNA isolation, the Benton Davis 
screening, the Northern blot analysis, and the sequencing were done 
as recently described (14, 15). 
The cDNA Library acid the Differential Screening.  A cDNA li- 
brary was prepared starting with 5 #g poly(A) + endophsmic retic- 
ulum mRNA of the 8-h PMA plus ionomycin-induced CHI mast 
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Strategene Inc., LaJolla, CA). Packaging of the recombinant phages 
was done with the Gigapack Gold system (Stratagene Inc.). About 
2  x  106  primary  clones  were  generated  and  amplified. 104 
amplified clones were then  differentially screened using radioac- 
tively labeled eDNA probes generated from 5/~g total RNA of 
uninduced and 8 h PMA plus ionomycin-induced CPII cells. Probes 
were synthesized using a preamplification kit system (Superscript; 
Bethesda Research Laboratories, Gaithersburg, MD) with 10 mM 
dATP, dGTP, TTP, and 100/xCi dCTP (Amersham International, 
Amersham,  Bucks, UK). 
Cells and Stimulation.  The CPII cell line is a recently established 
mouse mast cell line grown out of a spleen cell culture.  It is able 
to respond with histamine release upon IgE plus antigen stimula- 
tion and upregulates TNFcr  MIPlc~, JE, and 1I-3 at the transcrip- 
tional level. It is, however, negative for Ib4 transcriptional upregu- 
lation, which is characteristic for other mouse mast cell lines. Cells 
are cultured  with  10%  FCS and  10%  WEHI cell-conditioned 
medium. Stimulation is performed with 20 nM PMA (Sigma Chem- 
ical Co., Deisenhofen, Germany) and 200 nM ionomycin (Sigma 
Chemical Co.) or with 2 #g/ml monoclonal mouse IgE (Biomakor, 
Rehovot, Israel) and 100 ng/ml antigen (DNP-BSA; Calbiochem 
Corp.,  La Jolla, CA). Mast cells from the peritoneal cavity were 
isolated from the peritoneal washes of 9-too-old BALB/c female 
mice and further  purified by a Percoll gradient  as described (16). 
Purity was nearly 100%, as checked by Memacolor fast staining 
(Merck, Darmstadt,  Germany). 
Qualitative and Quantitative  PCR Analysis.  A 251-bp PstI frag- 
ment containing  the 5' end of the IL-4 receptor gene (generous 
gift of K. Koettnitz,  Sandoz Forschunginstitut)  was inserted into 
the  NsiI  restriction  site  (position  106) of our  newly isolated 
chemokine clone to generate a MIMIC for our PCR analysis. As 
primers for this analysis, we used a 23 met (5' CCAAGTGCTA 
GCCCAACCAGATG  3') and a 21 mer (5' GTGACATGAGGT- 
CTCCAGAGC  3 ~ at positions 77 and 552 of our clone, respec- 
tively. The underlined  sequence in the 23 mer represents a 3-bp 
mutation in the MARC sequence (original TGG) which was in- 
troduced to generate an NheI restriction  site for further cloning. 
As the control,/~-actin primers were used that were purchased from 
Clonetech  (Palo Alto,  CA). They amplify fragments  of 476 bp 
(chemokine), 540 bp (~-actin), and 727 bp (chemokine MIMIC), 
respectively. The cycle length  for amplification was 1 min each, 
temperatures were 94, 60, and 72~  respectively. The eDNA for 
this type of analysis was generated using the Superscript kit system 
(Bethesda Research Laboratories). One third of each reaction was 
analyzed on an agarose gel and quantified with the help of an image 
analyzer (Appligene, Illkirch,  France). 
Results and Discussion 
Cloning and Structural Analysis of MARC.  It is our aim 
to isolate novel transcriptionally upregnhted genes that could 
potentially play a role in acute and chronic diseases with mast 
cell involvement (allergic reactions type I, asthma). We there- 
fore differentially screened an induced eDNA library from 
the mouse mast cell line CPII. The library was made from 
the endoplasmic reticulum mRNA of cells stimulated with 
PMA/ionomycin, for 8 h to achieve maximal induction. Ra- 
dioactively labeled eDNA probes generated from the total 
RNA of unstimulated and 8-h stimuhted cells were used for 
the screening. Clones resulting in differential signals specific 
for the induced stage over two rounds of plaque purification 
were immediately subjected to a sequence analysis.  So far, 
computer-aided sequence comparisons of 50-100 nucleotides 
of this first sequence analysis identified several MlPlol- (17), 
ferritin- (18), and VL30 retrotransposon (19) sequences.  One 
currently unknown  eDNA clone was also purified and its 
complete nucleotide sequence and a translation  of its open 
reading frame is given in Fig.  1.  The clone is 746 bp long 
and codes for a small 97 AA very basic protein. At the NH2- 
terminus of the protein, hydropathy analysis according to both 
the Kyte Doolittle and Hoop and Woods algorithms,  indi- 
cated a leader peptide with a cleavage site prediction in avon 
Heijne analysis (20) at position 23/24. The lack of additional 
hydrophobic stretches that could serve as transmembrane do- 
mains immediately suggested that the gene might encode a 
small novel secretory protein.  At the nucleotide level,  two 
AUUUA sequences,  postulated to be involved in the mRNA 
stability of protooncogenes and lymphokines, are found (21, 
22). A slightly modified polyadenylation signal (5'TATAAA3') 
is present 20-bp upstream of the poly(A) stretch (23). Com- 
puter comparisons of the whole nucleotide and deduced amino 
acid sequences to the EMBL database (Version 30.0, June 1992) 
and the Swissprot. database (Version 23.0, June 1992) pointed 
out identities at the nucleotide (around 65%) and amino acid 
(around 50%) level to the mouse (m) JE gene and protein, 
and the human (hu) MCP1 gene and protein. The homology 
at nucleotide level to both genes is clustered in the coding 
region and is virtually absent in the 3' part of the sequences. 
A  significant, but decreased identity at protein level is seen 
with other members of the CC branch (Table 1). An amino 
acid comparison to the mJE protein,  the huMCPl protein, 
and two very recently only partially at protein level sequenced 
human isolates,  designated MCP2 (identical to former iso- 
late HC14) and MCP3, is given in Fig. 2. The degree of ho- 
mology and the conservation of the four important cysteines 
in the characteristic  conformation dearly group our gene into 
the RANTESAis chemokine family. It confirmed the initial 
TCTCACTCTCTITCTCCACC  20 
Met Arg Ile Set Ala Thr Leu LeU Cys Leu LeU Leu Ile Ala Ala Ala Phe Set  i# 
ATG AGG ATC TCT GCC ACG CTT CTG TOC CTG CTG CTC ATA GCC GCT GCT ~  AGC  74 
Ile Gln Val Trp Ala Gln Pro ASp G1y Pro ASh AIa Ser Thr CyS CyS Tyr Val  36 
ATC CAA GTG T~G GCC CAA CCA GAT GGG CCC RAT GCA TCC ACA TGC TGC TAT GTC 128 
Lys Lys Gln Ly$ Ile P~o Lys Arg ASh Leu Lys Set Tyr Arg Arg Ile Thr Set  54 
AAG AAA CAA AAG ATC CCC AAG AGG AAT CTC AAG AGC TAC AGA AGO ATC ACC AGT 182 
Ser Arg CWS Fro Trp Glu Ala Val Ile Phe Lys Thr LyS Lys Gly Met Glu Val  72 
AGT CGG TGT CCC TGG GAA GCT GTT ATC TTC AAG ACA AAG AAG GGC ATG GAA GTC 2)6 
Cys Ala Glu Ala His Gln Lys Trp Val Glu Glu A1a If@ Ala Tyr Leu Asp Met  e0 
TGT GCT GAA GCC CAT CAC  AAG TGG CTC GAG GAG OCT ATA C~A TAC TTA GAC ATG ~90 
Lys Thr Pro Thr Pro Lys Pro Stop  97 
AAA ACC CCA ACT CCA AAG CCT TGA AGAAATGTGt~-T~AA~CCTAGC~kGCCAAGA  353 
AGCAA~AATTCCTCA  TC~AATGTGTTGa~TCCTAA~3GAT  424 
AGG~'IY~  TA~  A~T~AAQTTATT~ATA'~TAT~&~  495 
~kTTAG  CCATGTACTT~TTTGAATGTAAAC~CCTCAT~AAC~TT~  566 
_  "J-A-.L-I.~l JuL. ,,~ L-A~-A-~.~.~-AU',L'ATTA  ~  63? 
G  TGCAAAGATTTTLq"r  q'JP,~Ax.-~.-~.-L-r~.,~2ATAAAATC.ATAAT~LT&YGAT~'L-~-,  ~-r~  T08 
ATGACTACT~GTT~TATAAAATGTA'FFz-I-L~AC (A30)  746 
Figure  1.  Nucleotide  and amino acid sequence of the MAKe clone. 
The amino acid sequence is giwn in the three letter code on top of each 
codon. (Arrow) Position of the predicted cleavage  site of the signal pep- 
tide. (U,derlined) Two ATTTA sequences speculated to be involved in 
mRNA stability in the 3' end of induced genes. Nudeotide and amino 
acid positions are always  given to the fight; amino acids are continuously 
numbered, including the leader peptide. These sequence  data are available 
from EMBL under accession number Z12297 as clone P3-6. 
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Murine  Percent  AA  Human  Percent  AA 
JE  48.5  99  MCP1  (total)  58.2  98 
MCP1  (mature)  56.0  75 
HC14 (MCP2)  49.4  77 
MCP3  56.5  69 
RANTES  39.6  91  R.ANTES  36.3  91 
MIP-lc~  36.3  91  MIP-lc~  33.0  94 
MIP-lfl  32.3  93  MIP-lfl  34.4  93 
TCA3  34.1  82  1-309  39.5  81 
The comparison shows percent amino acid identity of the complete 97 
AA MARC protein to all the other complete members of the CC branch. 
Only  in  the  case  of the  MCPl  (mature)  and  the  MCP2  and  MCP3 
chemokine were mature forms of the protein compared with the mature 
MARC protein (data for the leader peptide of MCP2 and MCP3 are not 
currently available).  The numbers given under AA show the length  of 
the proteins  that were compared.  AA  sequences  were taken from the 
following references: mJE (9); mR.ANTES (5); mMIP-lo~ (17); mMIP-lfl 
(24);  TCA3  (25);  huMCPl  (10);  huMCP2  (13);  huMCP3  (13); 
huRANTES  (26);  huMIP-ltx  (27);  huMIP-lfl  (28);  1-309  (29);  and 
huHC14  (12). 
-23  -i 
MARC  MRISATLLCLLLIAAAFSIQVWA 
mJE  MQVPVMLLGLLFTVAGWSIHVLA 
huMCPI  MKVSAALLCLLLIAATFIPQGLA 
huHCl4  (MCP2)  A 
huMCP3 
*...  **  **  *  * 
MARC 
mJE 
huMCPl 
huHCl4  (MCP2) 
huMCP3 
+i 
QPDG  PNAS  -TCCY-VKKQKI  PKRNLKSYRR  ITSSR~PW  36 
QPDAVNAPLT~CYSFTSKMI  PMSRLESYKR  ITSSR~  PK  38 
QPDAI  NAPVTCCYNFTNRKI  SVQRLASYRRITSSRC  PK  38  ::.:: 
QPDSVSI  P  IT~'~FNVINRKI  P  IQRLESYTRITNI~ PK  38 
KSTTC~YRFI  NKKI  PKQRLESYRRTTSSHCPR  32 
***  ***  .  .  **  .  .  ** 
MARC 
mJE 
huMCPl 
huHCl4  (MCP2) 
huMCP3 
EAVIFKTKKGMEV~AEAHQKWVEEAIAYLDMKTPTPKP  74 
EAVVFVTKLKR~ADPKKEWVQTYIKNLDRNQMRSEP  76 
EAVIFKTIVAKE~DPKQRWVQDSMDHLDKQTQTPKT  76 
EAVIFKTKRGKE~ADPKERWVRDSMKHLDQIFQNLKP  76 
EAVIFK  DKEI~ADPTQKWVQDFMKHLDKKTQTPKL  67 
****  *.**.  **  ** 
MARC 
mJE 
huMCPl 
huHCI4 
huMCP3 
(MCP2) 
TT  LFKTASAL  RSSA  PLNVKLT  RKSEANASTTFSTTT  S  S 
...................................... 
...................................... 
...................................... 
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assumption  that  the  clone  codes  for a  secretory  cytokine. 
Whether  it is the mouse homologue  of either  the  human 
MCP2  or MCP3  isolate cannot be decided  on the basis of 
this amino add comparison, because the identity/similarity 
values of MARC  to both proteins  are too similar.  Clearly 
arising from the data of Van Damme et  al.  (13) and from 
this article is that in the CC branch a MCP-like  subfamily 
(currently three members) exists, which has an  analogous coun- 
terpart  of JE-like  proteins  (now  two  members)  in  mouse. 
Expression  Analysis of  MARC.  Three parameters were im- 
portant for a potential linkage of this new gene to allergic 
conditions.  These are transcriptional upregulation after the 
allergic stimulus IgE plus antigen,  a relatively restricted ex- 
pression pattern,  and the finding of an in vivo correlate to 
the  situation in  our cell  line. 
First,  we determined whether  an allergic  provocation of 
our mast cell line also would be able to elicit an upregulation 
of this novel chemokine. Therefore, a Northern blot analysis 
was performed comparing the induction conditions used in 
the cDNA library construction with a stimulation with IgE 
plus antigen. As a probe, a cDNA fragment of our gene was 
used,  which  was first  tested  to  show it  had no  significant 
crosshybridization  to the murine JE gene under the condi- 
tions used, in spite of the 65% homology at nucleotide level. 
This Northern blot is shown in Fig. 3. Densitometric scan- 
ning and normalization to the fl-actin control gene revealed 
that IgE plus antigen  elicits  a response identical  to that of 
PMA/ionomycin over an 8-h incubation. The weak upregu- 
lation  seen with  ionomycin  alone parallels  effects  in  other 
mast cell lines and primary non-T and non-B cells with re- 
spect  to  the  transcriptional  induction  of such cytokines  as 
Ib3,  II.-4,  and GM-CSF  (30-32). 
To check the tissue distribution,  an identical analysis was 
performed on six different cell lines either unstimulated or 
MARC  ........... 
mJE  TSVGVTSVTVN  125 
huMCPl  ........... 
huHCl4  (MCP2)  ........... 
huMCP3  ........... 
Figure  2.  Amino  acid  comparison of MARC  with  mJE,  huMCPl, 
huHC14 (now MCP2), and MCP3 (hu, human; m, murine). All five pro- 
teins were compared over the full length using the Clustal V  program. 
(') Identities of all five proteins;  (.) similarities.  (8had~ Conserved four 
cystdnes characteristic for the RANTES/sis ~mily. The numbering of the 
mature proteins is given to the right, starting at Q  (+ 1). The leader pep- 
tides are given in the first line numbered from  -23 to A  (-1).  Informa- 
tion on the leader  peptide of MCP2  and  MCP3  is not available. 
FiEurr  3.  Northern blot analysis with MARC eDNA as a probe. (Left) 
7.5 ~g total RNA  of either unstimulated or stimulated CPII cells were 
analyzed.  The stimulus is indicated  on top, 28S and 185 size markers are 
shown to the left. At the bottom, a control hybridization  with the fl-actin 
gene is shown. Stimuli were used at the following concentrations:  PMA 
(20 nM);  ionomycin (200 rim); IgE (2/zg/ml);  DNP  [DNP-BSA]  (100 
ng/ml),  (Right) laser densitometry giving  corrected  scanning  units  of 
MARC  expression norm211~  to the fl-actin control gene. 
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cDNA and equal aliquots were amplified either with B-actin primers (lanes 
1 and 2) or MARC-specific primers (lanes 3-16).  (u) KNA of unstimu- 
lated cells; (i) KNA of 2 h IgE plus antigen-stimulated cells. Lanes I-4 
and 5-16  are a side-by-side experiment. Lanes 6-10  and 12-16 contain a 
MIMIC plasmid of MARC (see Materials and Methods) spiked in 10-fold 
serial dilutions from left to right. Lanes 5 and 11 show the side-by-side 
reaction without the spike. The concentration of the spike in lanes 6 and 
12 is 160 pg. 
stimulated for 8 h with PMA/ionomycin (cell lines: YAC, 
WEHI, BAF, EL-4F, 3T3, and L292) and six different mouse 
tissues (brain, heart, liver, lung, spleen, and testis). We failed 
to detect any transcriptional activity of our gene in these cell 
lines and tissues.  The constitutively expressed/3-actin con- 
trol gene, however, was detectable (data not shown). Although 
we cannot conclude from the limited number of  samples (total 
12) on a strict cell type specificity,  the expression pattern of 
our gene seems to be narrow. This is in contrast to most 
other  members of this  chemokine superfamily which are 
broadly expressed after a variety of stimuli. 
Even if it seems very unlikely that a cell line in the process 
of its establishment has gained a function in terms of a novel 
signal transduction pathway (induction of MARC via the 
Fc~KI in  our case),  it was important  to investigate the in 
vivo situation of mast cells with respect to our new chemokine. 
Therefore, peritoneal mouse mast cells were isolated as de- 
scribed in Materials and Methods and, because of the low 
amount of cells available after purification, analyzed by the 
PCR technology. In paraUel, an analogous experiment was 
also performed with the CPII cell line. The time of stimula- 
tion with IgE plus antigen was reduced, in comparison to 
the initial isolation and Northern blotting, to 2 h. This time 
point was determined to be optimal for expression in the CPII 
calls. A PCK analysis is shown in Fig. 4.  Lanes 1-4 give a 
side-by-side  reaction of/3-actin control primers and specific 
MARC primers.  It revealed minute levels of transcripts in 
the uninduced stage of the CPlI cells (see lane 3, top) which 
were not detected in the Northern blots. This suggests that 
a posttranscriptional stabilization  might contribute to the up- 
regulation of this gene, a fact that was also previously reported 
for the related mJE gene (33). It is likely that the same mech- 
anism is partially the cause of the band seen in the unstimu- 
lated in vivo mast cells (lane 3,  bottom). However, a certain 
degree of preactivation, especially of the in vivo cells, might 
also be an alternative explanation. Differences in the amount 
of the ~-actin control gene for the in vivo mast cells (lanes 
1 and 2; lower in the induced stage) are visible,  which indi- 
cates less input of cDNA of the induced cells in our analysis. 
This fact is important for a later quantification. Because the 
exponential  nature  of the  PCR  method  makes  a  direct 
quantification from these data impossible, a quantitative RT- 
PCR was performed on another cDNA aliquot. A plasmid, 
containing a 251-bp  unrelated insert in position 106 of our 
clone, was constructed to serve as the MIMIC in such a reac- 
tion. This plasmid was then spiked into constant amounts 
of cDNA, generated from unstimulated and stimulated CPII 
cells and in vivo mast cells, in 10-fold  serial dilutions. This 
is shown in Fig. 4, lanes 5-16.  For the CPII cells, this anal- 
ysis revealed an at least 100-fold difference of transcript levels 
between the uninduced and the 2-h induced stage. The exact 
quantification in this analysis is hampered by the fact that 
there was not enough spike (lanes 12-16)  to e~ciently com- 
pete for the amount of transcripts in induced CPII cells. The 
identical analysis for the in vivo mast cells revealed an ~10- 
fold induction with our IgE plus antigen stimulation ex vivo 
(compare lanes 9 and 10 with lanes 15 and 16).  As pointed 
out above, RNA/cDNA input levels in our analysis are lower 
for the induced stage and, therefore, we estimated a range 
of 5-20-fold for the upregulation of our gene in in vivo mast 
cells. This clearly shows that the new chemokine is transcribed 
from in vivo mast cells, which also respond with an upregu- 
lation of this gene to an Fc~RI challenge. We believe that 
a certain amount of preactivation, either already in vivo or 
in the process of the isolation of the cells  (mainly via the 
Ca  2  + concentration in the isolation buffer), is the reason for 
the smaller induction seen with these cells in comparison to 
the cell line. 
Our findings add to the four RANTESAis genes (TCA3, 
MIPlc~, MlPlfl, and JE), which are reported to be upregu- 
lated in different Ib3-dependent and -independent mouse 
mast cells after an Fc~KI challenge, another, novel member 
of this family (32). The production of  most of the chemotactic 
factors of the CC branch by various mast cell lines and sub- 
populations suggests a central regulatory role, not only for 
this cell type but also for the RANTES/sis family, in initi- 
ating cell infiltrations to allergic sites after an IgE plus an- 
tigen provocation. This further emphasizes the emerging pic- 
ture that the mast cell is not only a pure effector cell type, 
but that it also  has central regulatory functions in allergic 
events.  The finding that certain members of this family are 
more or less  specific for the recruitment of hematopoietic 
subpopulations (8) not only explains why such a broad spec- 
trum of factors is produced upon the same stimulus by one 
cell type, but also raises the question of for which subtype 
wiU MARC be the corresponding chemokine. 
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